NOVOSENSE (02676) announced that, as disclosed in the company's announcement dated January 2, 2026, it issued and allotted 1.0266 million H shares on January 7, 2026, due to the partial exercise of the over-allotment option.
NOVOSENSE (02676) announced that, as disclosed in the company's announcement dated January 2, 2026, it issued and allotted 1.0266 million H shares on January 7, 2026, due to the partial exercise of the over-allotment option.
Comments